baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Summit Therapeutics/ US86627R1023 /

2024-04-18 9:59:59 PM	Chg. -0.07	Volume	Bid-	Ask-	High	Low
3.51USD	-1.96%	31,974 Turnover: 113,391.23	-Bid Size: -	-Ask Size: -	3.67	3.50

GlobeNewswire 03-25 ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

GlobeNewswire 03-07 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 02-28 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 02-21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeut...

GlobeNewswire 02-08 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

GlobeNewswire 2022-03-17 Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter an...

GlobeNewswire 2022-02-09 Summit Therapeutics Announces Postponement of Its Planned Rights Offering

GlobeNewswire 2022-02-01 Dr. Maky Zanganeh Launches Personal Memoir, the Magic of Normal, to Honor February Cancer Survivor M...

GlobeNewswire 2022-01-25 Summit Therapeutics Announces Rights Offering

GlobeNewswire 2022-01-10 Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ...

GlobeNewswire 2022-01-05 Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual Conferen...

GlobeNewswire 2021-12-20 Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile Infecti...

GlobeNewswire 2021-11-15 Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and...

GlobeNewswire 2021-11-04 Entasis Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 2021-11-03 Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Exe...

GlobeNewswire 2021-10-11 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 2021-10-08 Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of...

GlobeNewswire 2021-10-04 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 2021-09-30 Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action...

GlobeNewswire 2021-09-24 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics...

GlobeNewswire 2021-08-11 Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 2021-08-11 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Si...

GlobeNewswire 2021-08-11 Summit Therapeutics Provides Update on Ri-CoDIFy Trials

GlobeNewswire 2021-07-14 Entasis Therapeutics Expands Executive Leadership Team with the Appointment of Anna Diaz Triola as C...

GlobeNewswire 2021-07-12 Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Va...

Summit Therapeutics/ US86627R1023 /

If you wish to receive reply to your feedback, please provide your email address.